AAAAAA

   
Results: 1-8 |
Results: 8
THE ACCURACY OF THE FREQUENCY-VOLUME CHART - COMPARISON OF SELF-REPORTED AND MEASURED VOLUMES - REPLY
Authors: HANSEN CP KLARSKOV P
Citation: Cp. Hansen et P. Klarskov, THE ACCURACY OF THE FREQUENCY-VOLUME CHART - COMPARISON OF SELF-REPORTED AND MEASURED VOLUMES - REPLY, British Journal of Urology, 82(5), 1998, pp. 776-777
THE ACCURACY OF THE FREQUENCY-VOLUME CHART - COMPARISON OF SELF-REPORTED AND MEASURED VOLUMES
Authors: HANSEN CP KLARSKOV P
Citation: Cp. Hansen et P. Klarskov, THE ACCURACY OF THE FREQUENCY-VOLUME CHART - COMPARISON OF SELF-REPORTED AND MEASURED VOLUMES, British Journal of Urology, 81(5), 1998, pp. 709-711
ESTRAMUSTINE PHOSPHATE VERSUS PLACEBO AS 2ND LINE TREATMENT AFTER ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATE-CANCER - DAPROCA STUDY-9002
Authors: IVERSEN P RASMUSSEN F ASMUSSEN C CHRISTENSEN IJ EICKHOFF J KLARSKOV P LARSEN E MOGENSEN P MOMMSEN S ROSENKILDE P
Citation: P. Iversen et al., ESTRAMUSTINE PHOSPHATE VERSUS PLACEBO AS 2ND LINE TREATMENT AFTER ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATE-CANCER - DAPROCA STUDY-9002, The Journal of urology, 157(3), 1997, pp. 929-934
ABSENCE OF HEPATIC ENZYME-INDUCTION IN PROSTATE-CANCER PATIENTS RECEIVING CASODEX (BICALUTAMIDE)
Authors: KAISARY A KLARSKOV P MCKILLOP D
Citation: A. Kaisary et al., ABSENCE OF HEPATIC ENZYME-INDUCTION IN PROSTATE-CANCER PATIENTS RECEIVING CASODEX (BICALUTAMIDE), Anti-cancer drugs, 7(1), 1996, pp. 54-59
THE STANDARDIZATION OF TERMINOLOGY OF FEMALE PELVIC ORGAN PROLAPSE AND PELVIC FLOOR DYSFUNCTION
Authors: BUMP RC MATTIASSON A BO K BRUBAKER LP DELANCEY JOL KLARSKOV P SHULL BL SMITH ARB
Citation: Rc. Bump et al., THE STANDARDIZATION OF TERMINOLOGY OF FEMALE PELVIC ORGAN PROLAPSE AND PELVIC FLOOR DYSFUNCTION, American journal of obstetrics and gynecology, 175(1), 1996, pp. 10-17
EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER
Authors: LUNGLMAYR G ALFTHAN O ALTWEIN JE BLACKLEDGE G BLACKLOCK NJ BONO A BOUFFIOUX C CHANNER K DEBRUYNE F DENIS L DISILVERIO F GRASSET D HAEFLINGER JM HARLAND S HEIJBROEK RP HOISAETER PA IVERSEN P JAEGER N KEUPPENS F KHOE GS KLARSKOV P KONTTURI M KUBER W KUMS JJM LARDENOYE JG LEDUC A LUNGLMAYR G MOEHRING K NEWLING D PAVONEMACALUSO M PERMI J RASMUSSEN F ROSSETTI SR SANDER S SARRAMON JP SMITH PH TVETER K TYRRELL CJ USAI E VALLANCIEN GMB VANCANGH PJ VARENHORST E WEISSBACH L WHELAN P WILLIAMS JL ZALCBERG J ZATTONI F DAWES PM
Citation: G. Lunglmayr et al., EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Anti-cancer drugs, 6(4), 1995, pp. 508-513
BIOFEEDBACK TREATMENT OF BLADDER DYSFUNCTION IN MULTIPLE-SCLEROSIS - A RANDOMIZED TRIAL
Authors: KLARSKOV P HEELY E NYHOLDT I ROTTENSTEN K NORDENBO A
Citation: P. Klarskov et al., BIOFEEDBACK TREATMENT OF BLADDER DYSFUNCTION IN MULTIPLE-SCLEROSIS - A RANDOMIZED TRIAL, Scandinavian journal of urology and nephrology, 1994, pp. 61-65
LONG-TERM RESULTS OF DANISH-PROSTATIC-CANCER-GROUP TRIAL-86
Authors: IVERSEN P RASMUSSEN F KLARSKOV P CHRISTENSEN IJ CHRISTENSEN MG FRIIS E HORNBOL P HVIDT V MOGENSEN P IVERSEN HG ROSE C KRARUP T LUND F PEDERSEN T SKAARUP P WOLF H
Citation: P. Iversen et al., LONG-TERM RESULTS OF DANISH-PROSTATIC-CANCER-GROUP TRIAL-86, Cancer, 72(12), 1993, pp. 3851-3854
Risultati: 1-8 |